Literature DB >> 22001159

Stress, depression and Parkinson's disease.

Ann M Hemmerle1, James P Herman, Kim B Seroogy.   

Abstract

In this review, we focus on the relationship among Parkinson's disease (PD), stress and depression. Parkinson's disease patients have a high risk of developing depression, and it is possible that stress contributes to the development of both pathologies. Stress dysfunction may have a role in the etiology of preclinical non-motor symptoms of PD (such as depression) and, later in the course of the disease, may worsen motor symptoms. However, relatively few studies have examined stress or depression and the injured nigrostriatal system. This review discusses the effects of stress on neurodegeneration and depression, and their association with the symptoms and progression of PD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22001159      PMCID: PMC3268878          DOI: 10.1016/j.expneurol.2011.09.035

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  154 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder.

Authors:  Giacomo Salvadore; Allison C Nugent; Herve Lemaitre; David A Luckenbaugh; Ruth Tinsley; Dara M Cannon; Alexander Neumeister; Carlos A Zarate; Wayne C Drevets
Journal:  Neuroimage       Date:  2010-11-10       Impact factor: 6.556

3.  The effect of depression on motor function and disease severity of Parkinson's disease.

Authors:  Spiridon Papapetropoulos; John Ellul; Andreas A Argyriou; Elisabeth Chroni; Nicoletta P Lekka
Journal:  Clin Neurol Neurosurg       Date:  2005-09-16       Impact factor: 1.876

Review 4.  The effects of stress on central dopaminergic neurons: possible clinical implications.

Authors:  J M Finlay; M J Zigmond
Journal:  Neurochem Res       Date:  1997-11       Impact factor: 3.996

5.  Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia.

Authors:  Angela J Grippo; Joseph Francis; Terry G Beltz; Robert B Felder; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2005-03-23

6.  Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism.

Authors:  Francisco Ros-Bernal; Stéphane Hunot; Maria Trinidad Herrero; Sebastien Parnadeau; Jean-Christophe Corvol; Lixia Lu; Daniel Alvarez-Fischer; María Angeles Carrillo-de Sauvage; Françoise Saurini; Christiane Coussieu; Kiyoka Kinugawa; Annick Prigent; Günter Höglinger; Michel Hamon; François Tronche; Etienne C Hirsch; Sheela Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-05       Impact factor: 11.205

7.  Decrements in nuclear glucocorticoid receptor (GR) protein levels and DNA binding in aged rat hippocampus.

Authors:  Erin K Murphy; Robert L Spencer; Kimberly J Sipe; James P Herman
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

Review 8.  Role of neurotrophic factors in the etiology and treatment of mood disorders.

Authors:  Ronald S Duman
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 9.  Stress-induced Parkinson's disease: a working hypothesis.

Authors:  Amanda D Smith; Sandra L Castro; Michael J Zigmond
Journal:  Physiol Behav       Date:  2002-12

10.  Stress-induced neurological impairments in an animal model of parkinsonism.

Authors:  A M Snyder; E M Stricker; M J Zigmond
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

View more
  51 in total

Review 1.  Functional and behavioral consequences of Parkinson's disease-associated LRRK2-G2019S mutation.

Authors:  Deanna L Benson; Bridget A Matikainen-Ankney; Ayan Hussein; George W Huntley
Journal:  Biochem Soc Trans       Date:  2018-12-04       Impact factor: 5.407

2.  Adjustment disorder and risk of Parkinson's disease.

Authors:  E Svensson; D K Farkas; J L Gradus; T L Lash; H T Sørensen
Journal:  Eur J Neurol       Date:  2016-01-12       Impact factor: 6.089

Review 3.  Mechanisms for alternative treatments in Parkinson's disease: acupuncture, tai chi, and other treatments.

Authors:  Bijan D Ghaffari; Benzi Kluger
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 4.  Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood.

Authors:  Paula Desplats; Ashley M Gutierrez; Marta C Antonelli; Martin G Frasch
Journal:  Neurosci Biobehav Rev       Date:  2019-11-05       Impact factor: 8.989

5.  Unpredictable Chronic Mild Stress Paradigm Established Effects of Pro- and Anti-inflammatory Cytokine on Neurodegeneration-Linked Depressive States in Hamsters with Brain Endothelial Damages.

Authors:  Ennio Avolio; Gilda Fazzari; Maria Mele; Raffaella Alò; Merylin Zizza; Wei Jiao; Anna Di Vito; Tullio Barni; Maurizio Mandalà; Marcello Canonaco
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

6.  Multimodal MRI evaluation of parkinsonian limbic pathologies.

Authors:  Ernest W Wang; Guangwei Du; Mechelle M Lewis; Eun-Young Lee; Sol De Jesus; Sangam Kanekar; Lan Kong; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2019-01-16       Impact factor: 4.673

Review 7.  An update on the diagnosis and treatment of Parkinson disease.

Authors:  Philippe Rizek; Niraj Kumar; Mandar S Jog
Journal:  CMAJ       Date:  2016-05-24       Impact factor: 8.262

8.  Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress.

Authors:  Anil Kumar; Barinder Singh; Jitendriya Mishra; Sangeeta Pilkhwal Sah; Raghavender Pottabathini
Journal:  Inflammopharmacology       Date:  2015-06-30       Impact factor: 4.473

Review 9.  VPS35 Parkinson's disease phenotype resembles the sporadic disease.

Authors:  Walter Struhal; Stefan Presslauer; Sabine Spielberger; Alexander Zimprich; Eduard Auff; Thomas Bruecke; Werner Poewe; Gerhard Ransmayr
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

10.  Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice.

Authors:  Ashok Jangra; Mohit Kwatra; Tavleen Singh; Rajat Pant; Pawan Kushwah; Yogita Sharma; Babita Saroha; Ashok Kumar Datusalia; Babul Kumar Bezbaruah
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.